Journal of the National Comprehensive Cancer Network

Final Weeks to Participate in the NCCN Guidelines User Survey! NCCN is reaching out to clinical oncology professionals to determine how to continually improve the NCCN Guidelines® and other valuable NCCN Content. Complete our 12-15 minute surveyby June 30, 2026, and be entered for a chance to win a one-year subscription to an NCCN derivative product of choice. US clinical oncology professionals: Take the survey here | International clinical oncology professionals: Take the survey here

The NCCN Payer Relations Resource Page is designed to support utilization management teams, medical directors, and peer reviewers in the application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and related NCCN Content into payer policy.

Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines for cancer prevention, screening, treatment, and supportive care.

The latest version of the National Comprehensive Cancer Network’s Distress Thermometer and Problem List is available for free in more than 70 languages. PLYMOUTH MEETING, PA [May 20, 2026] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—announces that the latest version of the NCCN Distress Thermometer and Problem List, a rapid validated screening tool (0-10 scale) is available in more than 70 languages to identify and address patient distress.

Researchers provide the most comprehensive evaluation of a widespread type of psychostimulant for cancer-related fatigue to date, based on meta-analysis from nine randomized clinical trials.

PLYMOUTH MEETING, PA [Wednesday, May 13, 2026]—Today, the National Comprehensive Cancer Network® (NCCN®), in collaboration with other organizations across the cancer community, released a consensus statement identifying the primary drivers of the persistent drug shortage crisis in the United States and proposing actionable policy solutions to protect access to critical cancer medications.

NCCN’s work to improve outcomes for people with cancer is recognized by independent organizations with a focus on life sciences, equity, and clarity. PLYMOUTH MEETING, PA [April 29, 2026] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—announces several recent external awards and publications honoring the work of NCCN’s dedicated staff.

Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives. PLYMOUTH MEETING, PA [April 28, 2026] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—has published a new book explaining the latest evidence and expert recommendations around prostate cancer screening.

The National Comprehensive Cancer Network announces funding for selected quality improvement research projects to utilize digital tools for improving decision-making and quality of life for people with CML. PLYMOUTH MEETING, PA [April 23, 2026] — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced funding awards for quality improvement initiatives in CML.

The National Comprehensive Cancer Network recognizes people whose leadership, commitment, and dedication helped NCCN break new ground to define and advance quality, effective, equitable, and accessible cancer care and prevention over the past year.